# Task Handoff

## Owner

chief-architect (team lead). Task D — Integration conclusion (Stage A). Written in the Stage A resume session, 2026-10-08, about 14:00Z.

## Task

Task D. Read the run-2 outputs (Tasks A/B/C/E and their re-checks) and the resume-session outputs (Tasks A2/B2/C2). Compare their conclusions, identify disagreements, decide whether the specifications are mutually consistent, and record the agent-team test evidence. BUILD_PLAN Phase 0 (Stage A). Documentation only.

## Status

COMPLETED.

**Integration conclusion:** the specifications are mutually consistent at the documentation level.
- Every HIGH finding raised in Stage A is resolved in the text.
- The clinical-safety-engineer's final Gate 6 documentation verdict is **PASS**.
- No behavior test exists yet. Every CS test is PENDING, and pending never counts as passing.
- Residuals are LOW or owner decisions, listed under Remaining issues. None blocks Phase 1.

## History (why this file is written late)

- **Run 1** (handoffs `…-stage-a-team-{product,evidence,safety}.md`): interrupted by a session limit. The lead fixed the run-1 findings in ADR-034 to ADR-036.
- **Run 2** (`…-stage-a-team2-{product,evidence,safety,backend}.md` plus the three `…-recheck.md` files):
  - Tasks A, B, C and E completed.
  - Task D stayed pending, blocked by A/B/C. The task list was verified at `~/.claude/tasks/session-b983a4a0/4.json` on resume.
  - The lead then wrote ADR-043, but the session hit its limit before this synthesis, before the BUILD_PLAN alignment and before the commit.
  - PROJECT-STATUS already cited this file and claimed "all residuals fixed". That was premature (S3-08, P2-15).
- **Resume session** (this one): verified the repository state and ran staged single-agent reviews:
  - clinical-safety-engineer (`…-stage-a-resume-safety.md`)
  - evidence-research-engineer (`…-stage-a-resume-evidence.md`)
  - product-clinical-architect (`…-stage-a-resume-product.md`)

  The lead applied ADR-044 and ADR-045 and wrote this synthesis.

## What Changed

### 1. Comparison of conclusions (A / B / C)

| Topic | Product (A, A2) | Evidence (B, B2) | Safety (C, C2) | Agreement |
|---|---|---|---|---|
| Pipeline order: facts → concepts → queries → retrieval → validation → dedup/rank → storage → [R2 candidates → supporting/contradicting/missing → citations ⊆ citable bundle → synthesis] → clinician review | consistent | consistent after B2 fixed EVIDENCE-SOURCES §17 (sanitizer step, job 13, "citable") and the lead fixed TESTING, BUILD_PLAN and PRODUCT_SPEC wording | consistent | **agree** |
| Model output reaching notes or evidence unchecked | P4-01: unchecked `notDiscussed` marker; P4-03: job-14 prose | E3-01/E4-01: concept key and category leaks | S2-02, S2-14, S4-01, S6-01 | **agree on the problem**. Closed by ADR-043 → ADR-044 → ADR-045 |
| Rule 19 reject vs keep | P4-02: rejection silently loses true findings | — | S4-01 wanted rejection; S6-01 showed keep-and-flag must not hide allergies | **Disagreement, resolved:** keep-and-flag with ineligibility plus the allergy exception (ADR-045). Accepted by safety (final PASS) and grounded in product's proposal |
| UNMAPPED keys | FR-17.8 notice | the notice must be scoped to routed categories; wording "not in ClinNote's concept list" | supports it; not a Gate 6 blocker | **agree** (product revised FR-17.8 after evidence's reply) |
| Family history and CANCER_INFO | — | E3-02 (category keyed) | CS-38 B | **agree** (EVIDENCE-SOURCES §17 table keyed by FactCategory; safety PASS) |
| Caregiver/proxy speech | raised; scope not decided | — | interim rule accepted | **owner decision:** OD-012 |

No unresolved disagreement remains between the three specialists.

### 2. Decisions recorded this session

- **ADR-044:**
  - value grounding (`AI.md` §5.1 rule 17)
  - concept key computed from the fact's own value (rule 16)
  - deterministic context check for negation, hedge, hypothetical, experiencer and question, scoped to the clause (rule 19)
  - unclear audio (rule 18)

  Resolves S2-02, S2-14, S4-01, S4-02 and S5-01.
- **ADR-045:**
  - code-decided NOT_DISCUSSED
  - visible discards
  - keep-and-flag (CONTEXT_UNCLEAR) with the allergy exception
  - confirm requires a category
  - note placeholder
  - code-rendered comparison
  - UNMAPPED re-extraction matching
  - conditional advice is never a FollowUp

  Resolves P4-01 to P4-05 and S6-01 to S6-04.
- **OD-012:** caregiver/proxy consultations (owner, before Phase 10).
- Clarifications without an ADR (they summarize existing decisions):
  - DATA_MODEL §3 "Layered fact model": source type, derivation, information status, confirmation status, lifecycle, historical, traceability
  - DATA_MODEL §4.15 "Fact participation in automatic evidence retrieval": ACTIVE / UNKNOWN / NEGATIVE / NOT_DISCUSSED / REJECTED / SUPERSEDED / SOURCE_CHANGED / CONTEXT_UNCLEAR / OPEN-conflict / UNMAPPED
- **CLINICAL-SAFETY** (safety-owned):
  - CS-45 (unclear audio) and CS-46 (context)
  - CS-04 D, CS-18 C, CS-19 C, CS-24 B
  - CS-29 aligned
  - CS-38 A variant and the B family-history case
  - coverage table extended to all required corpus areas
  - Gate 6 range CS-01…CS-46

### 3. Finding dispositions

**F-01…F-14:** RESOLVED in the specification. Behavior tests are defined and PENDING (no implementation). Details are in `PROJECT-STATUS.md`.

| Series | Raised in | Final disposition |
|---|---|---|
| P2-01…P2-15 | run 2 A | all RESOLVED. P2-02 resolved in the resume (FR-22.3, SPEECH §11). P2-15 is resolved by this file |
| E2-01…E2-14 | run 2 B | all RESOLVED. E2-03, E2-09 and E2-13 resolved in the resume (B2) |
| S2-01…S2-15 | run 2 C | all RESOLVED. S2-02 and S2-14 (HIGH) resolved by ADR-043 + ADR-044 (safety final verdict) |
| backend F-1…F-8 | run 2 E | all RESOLVED: ADR-042, IC-004/IC-013/IC-015/IC-019a/IC-019b, AGENT-TASK-GRAPH (lead-verified in the resume) |
| S3-01…S3-08 | run-2 safety re-check | S3-01…S3-07 RESOLVED (C2). S3-08 (premature status claim) is resolved by the PROJECT-STATUS rewrite in this session |
| E3-01…E3-06 | run-2 evidence re-check | all RESOLVED (B2) |
| P3-01…P3-07 | run-2 product re-check | all RESOLVED (A2). The P3-03 LOW residual ("Re-run evidence search first") was fixed in UI-UX Screen 11 |
| S4-01 (HIGH), S4-02, S5-01 | resume C2 | RESOLVED (ADR-044 decision 5, rules 9/19) |
| E4-01 (HIGH, the same issue as S4-01), E4-02…E4-07 | resume B2 | RESOLVED: rule 19, DATA_MODEL §6 rule 19, §4.16, §4.5, the EVIDENCE-SOURCES §17 table, and the CS-33/CS-38 cases via safety |
| P4-01 (HIGH), P4-02…P4-07 | resume A2 | RESOLVED (ADR-045, FR-17.8, the UI-UX label rows, the ADR-038 annotation) |
| P4-08 | resume A2 | ACCEPTED trade-off: history obtained by question and answer is AI_EXTRACTED and needs confirmation. It is the intended safety bias; no change |
| S6-01 (HIGH), S6-02…S6-04 | resume C2 | RESOLVED (ADR-045 decision 3; DATA_MODEL §3.3a/§5.3/§10.3) |

### 4. Gate 6 (clinical safety): final evaluation at Stage A

The criteria are those of `QUALITY-GATES.md` Gate 6. "Applicable" is defined in `CLINICAL-SAFETY.md` §18a as every part scheduled at or before the current phase. At Phase 0 that set is empty: the first scheduled parts are in Phase 4.

| Criterion | Status | Evidence | Owner | Required correction |
|---|---|---|---|---|
| All applicable CS-01…CS-46 (incl. CS-16a) pass; pending ≠ passing | NOT YET APPLICABLE (empty applicable set; nothing counted as passing) | §18a; no `tests/` directory | clinical-safety-engineer, qa-test-engineer | the Phase 4 parts must pass at Phase 4 |
| The phase's safety corpus cases exist | NOT YET APPLICABLE (corpus built in Phase 6) | `TESTING.md` §13a; `BUILD_PLAN.md` Phase 6 | clinical-safety-engineer + qa-test-engineer | build in Phase 6 |
| `possibilitiesEnabled` OFF → no R2 job (CS-37) | NOT YET APPLICABLE (behavior); spec consistent | ADR-042, IC-019a, CS-37 A–D | ai, backend | none |
| No diagnosis/prescribing/dose/probability output | NOT YET APPLICABLE (behavior); spec consistent | `AI.md` §5.1 rules 6, 13, 15, 17, 19, 20 | ai-clinical-engineer | none |
| NOT_DISCUSSED never rendered as negative/normal | NOT YET APPLICABLE (behavior); spec consistent | rules 7 and 20; CS-04 A–D, CS-20, CS-41 | ai-clinical-engineer | none |
| Citations only from provider responses | NOT YET APPLICABLE (behavior); spec consistent | rules 5, 10, 11; CS-16, CS-16a | evidence-research-engineer | none |
| Review of AI/evidence/data changes completed | **PASS** (specification review) | `2026-10-08-stage-a-resume-safety.md`, Addenda 1–7 | clinical-safety-engineer | none |

**Gate 6 documentation verdict: PASS** (clinical-safety-engineer, final, Addendum 7). Gate 6 was not weakened. Its range was extended from CS-44 to CS-46, which is more restrictive.

### 5. Agent-team validation evidence

| Item | Run 2 (previous session) | Resume session (this one) |
|---|---|---|
| Agents spawned | product, evidence, safety, backend (team `session-b983a4a0`) | safety, evidence and product, staged one or two at a time as background in-process teammates; backend **not** spawned (Task E verified by the lead) |
| Session-limit incidents | the lead hit its limit after the re-checks (no synthesis, no commit). Run 1 was also interrupted | **none.** No teammate or lead hit a limit |
| Messaging | `[STAGE-A2-MSG]` product→evidence, evidence→safety, safety→product, recorded in the run-2 handoffs | evidence→safety `[STAGE-A-RESUME-MSG]` with a reply (E4-01 confirmed as S4-01); product→evidence `[STAGE-A-RESUME-MSG]`, where the reply arrived after product's first handoff draft and FR-17.8 was then revised; lead↔safety 6 rounds; lead→evidence 1 round. All are recorded in the handoffs' Messages tables |
| Task dependencies | Task D blocked by A/B/C (observed) | Task D (#4) blockedBy #1–#3 in this session's list |
| Plan approval | Task E: backend 7B plan v1 REJECTED, v2 APPROVED (`…-team2-backend.md`) | not repeated |
| Quality-gate hook probes | the run-2 probe output was kept only in a session scratchpad and is **not preserved**, so it is not cited as evidence | re-run live, see Tests: ownerless task BLOCKED; tests-required without results BLOCKED; safety-sensitive without "Safety review: PASS" BLOCKED; dependent completion first **NOT blocked** (bug), fixed, then BLOCKED |
| Release of agents | — | shutdown_request → shutdown_approved for safety, evidence and product |

Hook defects found and fixed this session (`.claude/hooks/task_gate.py`):
1. Relative `Handoff:` paths were resolved against the session cwd, so a session working in `docs/` failed the gate. They now also resolve against `CLAUDE_PROJECT_DIR`.
2. The dependency check silently skipped team task lists stored in a directory matching neither the session id nor the team name. It now falls back to a task list whose `<id>.json` has the same subject.

Both fixes have regression tests.

## Files Changed

This file (new). The other changes of the session are listed in `docs/BUILD_REPORT.md`.

## Interfaces Changed

None. No IC entry changed this session.

## Dependencies

Relied on:
- the run-1, run-2 and resume handoffs listed above
- `docs/DECISIONS.md` ADR-021…ADR-045 and OD-001…OD-012
- `docs/QUALITY-GATES.md` Gate 6
- `docs/CLINICAL-SAFETY.md` §18/§18a

Depends on this: `PROJECT-STATUS.md`, `BUILD_REPORT.md` and ADR-033 (which cites this file).

## Tests

- `python3 -I -m unittest discover -s .claude/hooks/tests`: Ran 23 tests, OK (2026-10-08, Linux Codespace, Python 3). This includes the 2 regression tests added this session.
- Live hook probes (TaskCreate/TaskUpdate in this session, 2026-10-08 about 13:59Z):
  - **P1:** ownerless TaskCreate → `BLOCKED … has no 'Owner: <agent-name>' line`
  - **P2:** Tests-required without results → `BLOCKED … handoff '## Tests' section has no test command/result counts`
  - **P3:** Safety-sensitive without review → `BLOCKED … has no 'Safety review: PASS'`
  - **P4:** dependent task with a pending blocker:
    - before the fix: completed (defect)
    - after the fix: `BLOCKED … depends on unfinished task(s) #9 (pending)`

  The probe tasks were deleted afterwards.
- Cross-reference audit script (every ADR/OD/CS ID referenced in spec, agent and rule files exists; the CS range is CS-01…CS-46; every cited handoff exists; no `AI_INFERRED` value): PASS after this file was written. See BUILD_REPORT.
- No application tests exist (no application code).

## Evidence

- `~/.claude/tasks/session-b983a4a0/{1..5}.json`: run-2 status A/B/C/E completed, D pending, blockedBy [1, 2, 3].
- `docs/agent-handoffs/2026-10-08-stage-a-resume-safety.md` Addendum 7: "S6-01…S6-04 RESOLVED; Gate 6 documentation verdict PASS".
- `docs/agent-handoffs/2026-10-08-stage-a-resume-evidence.md`: E2/E3 all RESOLVED; Messages table.
- `docs/agent-handoffs/2026-10-08-stage-a-resume-product.md`: P2-02, P3-01…P3-07 RESOLVED; P4 findings; Messages table.
- `docs/DECISIONS.md` ADR-044, ADR-045, OD-012.
- `docs/DATA_MODEL.md` §3 (layered model table), §3.3a, §4.15 (participation table), §10.3.
- `docs/AI.md` §5.1 rules 16–20.

## Known Limitations

- The verdict covers specification consistency only. Behavior is unproven until the CS parts pass with test output, from Phase 4 on.
- Run-2 quality-gate probe output was not preserved. Only this session's probes are evidence.

## Risks

- Rules 17 and 19 may reject many legitimate extractions at Phase 10. The mitigation is defined: discards are visible, and the code tables are extended through tested changes, never by relaxing the rule (ADR-044 future review condition).
- Many "AI inference — verify" labels on history obtained by question and answer (P4-08) add review load. This is accepted.

## Remaining Issues (none blocks Phase 1)

- Owner decisions:
  - OD-001 (Phase 8)
  - OD-002 (Phase 10)
  - OD-006 (Phase 20)
  - OD-007 (before Phase 8)
  - OD-010
  - OD-011 (Phase 11)
  - OD-012 (Phase 10)
  - the ADR-025 formal regulatory assessment (before any R2 release, before R3, before Phase 24)
- Provider details are VERIFY BEFORE IMPLEMENTATION at each phase.

## Receiving Agent

project owner (review of Stage A). REVIEW REQUIRED: yes, before Phase 1 is authorized.

## Next Action

Owner reviews Stage A. On explicit instruction: BUILD_PLAN Phase 1, Repository Foundation (devops-android-release-engineer). **Not started.**
